Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Apr;14(2):195-203.
doi: 10.1007/s11926-011-0234-2.

Association between gout and all-cause as well as cardiovascular mortality: a systematic review

Affiliations
Review

Association between gout and all-cause as well as cardiovascular mortality: a systematic review

Kathrin Lottmann et al. Curr Rheumatol Rep. 2012 Apr.

Abstract

Gout affects 1% to 2% of the population, and the prevalence is increasing due to changes in diet and the ageing of the population. Its development and risk factors have been explored frequently, and recommendations for the diagnosis and management of gout implemented. Nevertheless, there is a lack of knowledge regarding the long-term impact on gouty patients. This systematic review therefore evaluates the association between gout and all-cause as well as cardiovascular mortality. A systematic literature search was performed, and seven long-term studies were ultimately analyzed. Six of them used multivariate regressions to assess the adjusted mortality ratio in gouty patients with reference to patients without the disorder. Despite differences in study designs, study populations, and definitions of gout, the results were consistent: There was an independent association between gout and all-cause as well as cardiovascular mortality. Knowing that patients with gout are at risk emphasizes the need for adequate care.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow diagram of study identification and selection. (Adapted from Khan et al. [16])

Similar articles

Cited by

References

    1. Zhang W, Doherty M, Pascual E, et al. EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies including Therapeutics (ESCISIT) Ann Rheum Dis. 2006;65:1301–1311. doi: 10.1136/ard.2006.055251. - DOI - PMC - PubMed
    1. Doherty M. New insights into the epidemiology of gout. Rheumatology. 2009;48(Suppl 2):ii2–ii8. doi: 10.1093/rheumatology/kep086. - DOI - PubMed
    1. Tausche AK, Jansen TL, Schröder HE, et al. Gout – current diagnosis and treatment. Dtsch Arztebl Int. 2009;106:549–555. - PMC - PubMed
    1. Gresser U. Diagnosis and therapy of gout. Dtsch Artzebl. 2003;100:2862–2870.
    1. Sutaria S, Katbamna R, Underwood M. Effectiveness of interventions for the treatment of acute and prevention of recurrent gout—a systematic review. Rheumatology. 2006;45:1422–1431. doi: 10.1093/rheumatology/kel071. - DOI - PubMed